Detection of Specific Glycan Moieties on the Cell Surface
细胞表面特定聚糖部分的检测
基本信息
- 批准号:8349512
- 负责人:
- 金额:$ 18.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AlkynesAntibodiesAzidesBiotinCatalytic DomainCell membraneCell physiologyCell surfaceCellsChemicalsComplexConfocal MicroscopyCoupledDetectionDevelopmentEnvironmentEnzymesExcisionFamilyFlow CytometryGalactosidaseGalactosyltransferasesGlycoconjugatesHela CellsHumanInflammationLabelLectinLifeMalignant NeoplasmsMalignant neoplasm of cervix uteriMembraneMetal Binding SiteMetalsMethodsMonosaccharidesMutateMutationNeuraminidasePathologyPolysaccharidesProcessSamplingSialic AcidsSignal TransductionSiteSpecificityStreptavidinStructureSurfaceWestern BlottingWorkbasecancer cellcell fixingcofactordensityglycosylationglycosyltransferaselactosaminemutantnovelsugartool
项目摘要
In the present work, we have used mutant galactosyltransferases previously developed in our lab to detect GlcNAc and LacNAc on the surface of human cervical cancer cells (HeLa). The mutant enzymes have a cavity that has been carved in the donor site to accommodate UDP-Gal with a chemical handle at C2, such as azide (GalNAz) or keto group (C2-keto-Gal). The chemical handles are used for conjugation with fluoroprobes or biotin carrying bio-orthogonal group to detect the acceptor GlcNAc or LacNAc. We are using a double mutant of beta-1-4-galactosyltransferase-1 (beta-1,4GalT-1), Y289L-M344H-beta-1,4Gal-T1, that transfers GalNAz to GlcNAc in the presence of Mg2+, for detecting GlcNAc residue on the surface of live cells. The Tyr289Leu (Y289L) mutation allows the carving of the cavity to accommodate UDP-GalNAz, whereas the second mutation, Met344His (M344H), located in the enzyme's metal binding site, changes the metal cofactor requirement from Mn2+ to Mg2+. Since Mn2+, in contrast to Mg2+, is toxic to the cells, the Mg2+ dependent enzyme is very useful for labeling of live cells. Detection is investigated using confocal microscopy and flow cytometry. Green membrane fluorescent signal (corresponding to DIBO-Alexa 488) is detected on the HeLa cells only when cells are pre-treated with sialidase and galactosidase enzymes, indicating that glycans with free GlcNAc residues are not abundant on the surface of HeLa cells. The LacNAc moiety on the cell surface is detected using alpha-1,3-galactosyltransferase (alpha-1,3GalT) mutant enzyme, alpha-1,3GalT-280AGG282 , which transfers GalNAz or C2-keto-Gal to N-acetyl-lactosamine (LacNAc). The GalNAz or C2-keto-Gal labeled glycans are coupled with alkyne- or aminooxy-biotin, respectively. On fixed cells, coupled biotin is detected with streptavidin-Alexa Fluor 488. On extracts, coupled biotin is detected with streptavidin-HRP. Fluorescent signal is detected on cell membranes, as opposed to control samples where no UDP-GalNAz is present. Cells that are pre-treated with sialidase, increased the signal intensity, indicating that the density of exposed LacNAc residues is augmented by the removal of sialic acid. Similar results are obtained by Western Blot analysis. In conclusion, the use of Y289L-M344H-beta-1,4Gal-T1 and alpha-1,3GalT-280AGG282 enzymes, together with other glycosyltransferases currently being produced in our lab, could be powerful tools to investigate the cells glycophenotype with high specificity.
在目前的工作中,我们已经使用了先前在实验室中开发的突变体半乳糖基转移酶来检测人宫颈癌细胞(HELA)表面上的GlcNAC和LACNAC。突变酶的腔体已在供体部位雕刻,以适应C2处于C2的化学手柄的UDP-GAL,例如叠氮化物(Galnaz)或Keto组(C2-Keto-Gal)。该化学手柄用于与含有生物正交组织的氟检测或生物素结合,以检测受体GlcNAC或LACNAC。我们使用的是β-1-4-半乳糖基转移酶-1(β-1,4GALT-1),Y289L-M344H-BETA-1,4GAL-T1的双突变体,该突变体在MG2+的情况下将Galnaz转移到GlcNAC上,以检测GLCNAC,用于检测GLCNAC在活细胞表面上的glcnac残基。 Tyr289Leu(Y289L)突变允许雕刻腔体可容纳UDP-GALNAZ,而位于酶的金属结合位点中的第二个突变MET344HI(M344H)将金属辅因子的需求从MN2+到MG2+。由于MN2+与MG2+相反,对细胞有毒,因此MG2+依赖性酶对标记活细胞非常有用。使用共聚焦显微镜和流式细胞仪研究检测。仅当细胞与唾液酸酶和半乳糖苷酶预先治疗时,才在HeLa细胞上检测到绿色膜荧光信号(对应于Dibo-alexa 488),这表明具有游离GlcNAC残基的Glycans在HELA细胞表面上不丰富。 使用alpha-1,3-乳糖基转移酶(alpha-1,3galt)突变酶检测到细胞表面的LACNAC部分,Alpha-1,3Galt-280AGG282,将其转移到galnaz或C2-Keto-Gal或N-乙酰基合素(lacnac)。 galnaz或C2-keto-gal标记的聚糖分别与炔烃或氨基氧基 - 生物素耦合。在固定细胞上,用链霉亲和素 - 埃拉克萨荧光488检测到偶联的生物素。在提取物上,用链霉亲蛋白-HRP检测到偶联的生物素。在细胞膜上检测到荧光信号,而不是在没有UDP-galnaz的对照样品上检测到。用唾液酸酶预处理的细胞增加了信号强度,表明暴露于LACNAC残基的密度通过去除唾液酸而增强。通过Western印迹分析获得了类似的结果。总之,使用Y289L-M344H-BETA-1,4GAL-T1和Alpha-1,3GALT-280AGG282酶以及我们实验室中目前正在生产的其他糖基转移酶的酶的使用,可以是研究具有高特异性的糖脂型的强大工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pradman K Qasba其他文献
Pradman K Qasba的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pradman K Qasba', 18)}}的其他基金
Structural Studies and 3D Structure Determination of Recombinant <FONT FACE=symb
重组体的结构研究和 3D 结构测定 <FONT FACE=symb
- 批准号:
6433157 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
Oligosaccharide substrate interactions with beta-1,4-Ga
寡糖底物与 beta-1,4-Ga 的相互作用
- 批准号:
6944635 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
Oligosaccharide substrate interactions with beta-1,4-Gal
寡糖底物与 β-1,4-Gal 的相互作用
- 批准号:
7291793 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
Oligosaccharide Substrate and Inhibitor Interactions with beta-1,4-Gal-T1
寡糖底物和抑制剂与 β-1,4-Gal-T1 的相互作用
- 批准号:
7965207 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
Oligosaccharide Substrate and Inhibitor Interactions with beta-1,4-Gal-T1
寡糖底物和抑制剂与 β-1,4-Gal-T1 的相互作用
- 批准号:
7732974 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
Using Glycosyltransferases for Conjugation of Single-Chain Antibodies and Lipids
使用糖基转移酶缀合单链抗体和脂质
- 批准号:
8157471 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
PRINCIPALS OF CONFORMATIONAL ANALYSIS OF CARBOHYDRATES - A TEXT BOOK
碳水化合物构象分析原理 - 教科书
- 批准号:
6289310 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
Structure-Function Studies and Design of Novel Glycosyltransferases
新型糖基转移酶的结构功能研究和设计
- 批准号:
7965164 - 财政年份:
- 资助金额:
$ 18.95万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing a robust method for analyzing transcription factor mediated chromatin interactions
开发一种稳健的方法来分析转录因子介导的染色质相互作用
- 批准号:
10667811 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10504301 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10697334 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
聚乙二醇免疫原性对植入物生物相容性的影响
- 批准号:
10809875 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别: